Literature DB >> 29885932

Questionable specificity of histologic findings in calcific uremic arteriolopathy.

Carla L Ellis1, W Charles O'Neill2.   

Abstract

A variety of criteria exist for histopathologic diagnosis of calciphylaxis, also known as calcific uremic arteriolopathy but data on their specificity are limited. To assess this, histologic findings of 38 skin biopsies performed for a suspicion of calcific uremic arteriolopathy were compared with histologic findings in skin obtained from healthy margins of 43 amputations in patients with end-stage renal disease (ESRD) without evidence of calcific uremic arteriolopathy. Abnormalities in small arteries or arterioles were present in 35% of amputation specimens and 55% of skin biopsies, and among these only thrombosis but not calcification was significantly more prevalent in skin biopsies. The prevalence of extravascular calcification did not differ. Vascular lesions were more common in skin biopsies from patients with high clinical suspicion of calcific uremic arteriolopathy (81%), significantly driven by increases in both calcification and thrombosis, compared to amputations (35%). The combination of medial calcification and thrombosis was six-fold more prevalent in high-suspicion skin biopsies than in amputation specimens. The location of affected vessels did not differ. In two autopsy cases, some but not all findings of involved skin were also present in uninvolved skin. Thus, histopathologic findings historically associated with calcific uremic arteriolopathy can also occur in viable tissue from unaffected patients with ESRD, calling into question the specificity of individual histologic findings for calcific uremic arteriolopathy. However, the combination of medial calcification and thrombosis was rare in unaffected patients and may provide a higher degree of specificity.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  calciphylaxis; end-stage renal disease; histology; vascular calcification

Mesh:

Year:  2018        PMID: 29885932     DOI: 10.1016/j.kint.2018.03.016

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.

Authors:  Hester Colboc; Philippe Moguelet; Dominique Bazin; Priscille Carvalho; Anne-Sophie Dillies; Guillaume Chaby; Hervé Maillard; Diane Kottler; Elisa Goujon; Christine Jurus; Marine Panaye; Vincent Frochot; Emmanuel Letavernier; Michel Daudon; Ivan Lucas; Raphaël Weil; Philippe Courville; Jean-Benoit Monfort; François Chasset; Patricia Senet
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

2.  Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility.

Authors:  Tomohiro Saito; Yuuki Mima; Motonori Sugiyama; Nozomi Miyazawa; Ayana Iida; Nobuhiro Kanazawa; Taihei Suzuki; Yasuto Shikida; Toma Hamada; Yukihiro Wada; Masahide Mizobuchi; Hirokazu Honda
Journal:  CEN Case Rep       Date:  2019-12-17

3.  Calciphylaxis: a conundrum for patients and nephrologists?

Authors:  Marzia Pasquali; Natalia De Martini; Sandro Mazzaferro
Journal:  J Nephrol       Date:  2019-08-30       Impact factor: 3.902

4.  Correlation between clinical and pathological features of cutaneous calciphylaxis.

Authors:  Puja Dutta; Kristine M Chaudet; Rosalynn M Nazarian; Daniela Kroshinsky; Sagar U Nigwekar
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

5.  Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.

Authors:  Raphaël Gaisne; Morgane Péré; Victorio Menoyo; Maryvonne Hourmant; David Larmet-Burgeot
Journal:  BMC Nephrol       Date:  2020-02-26       Impact factor: 2.388

6.  Success of small-dose fractionated sodium thiosulfate in the treatment of calciphylaxis in a peritoneal dialysis patient.

Authors:  Yuan Lu; Lei Shen; Ling Zhou; Deyu Xu
Journal:  BMC Nephrol       Date:  2022-01-03       Impact factor: 2.388

7.  Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.

Authors:  Irene Ruderman; Tim D Hewitson; Edward R Smith; Stephen G Holt; Belinda Wigg; Nigel D Toussaint
Journal:  BMC Nephrol       Date:  2020-07-16       Impact factor: 2.388

8.  Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.

Authors:  Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm; Nikolaus Marx
Journal:  Circulation       Date:  2021-03-15       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.